Eric Carter
Direttore/Membro del Consiglio presso AEON BIOPHARMA, INC.
Patrimonio netto: - $ in data 31/05/2024
Profilo
Dr. Eric G.
Carter is an Independent Director at AEON Biopharma, Inc. He is on the Board of Directors at AEON Biopharma Sub, Inc., AEON Biopharma, Inc. and Visgenx, Inc. Dr. Carter was previously employed as a Chief Medical Officer by Alder Biopharmaceuticals, Inc., an Independent Director by Adverum Biotechnologies, Inc., a Chief Medical Officer & Senior Vice President by Allergan, Inc., a Chief Scientific & Medical Officer by King Pharmaceuticals, Inc., a Vice President & Global Head-Medical Affairs by GSK Plc, a Chief Marketing Officer by IACTA Pharmaceuticals, Inc., and an Associate Professor by The University of North Carolina at Charlotte.
He also served on the board at Bioniz Therapeutics, Inc. He received his undergraduate degree from the University of London, a doctorate degree from the University of Miami, a doctorate degree from The University of Miami Leonard M.
Miller School of Medicine and a doctorate degree from the University of Cambridge.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 26/04/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Posizioni attive di Eric Carter
| Società | Posizione | Inizio |
|---|---|---|
| AEON BIOPHARMA, INC. | Direttore/Membro del Consiglio | 01/06/2023 |
AEON Biopharma Sub, Inc.
 AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | Direttore/Membro del Consiglio | 24/07/2023 |
Visgenx, Inc.
 Visgenx, Inc. BiotechnologyHealth Technology Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | 01/01/2022 |
Precedenti posizioni note di Eric Carter
| Società | Posizione | Fine |
|---|---|---|
Bioniz Therapeutics, Inc.
 Bioniz Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Bioniz Therapeutics, Inc. operates as a biopharmaceutical firm. The firm engages in the development of peptide therapeutics that selectively and simultaneously inhibit multiple cytokines for the treatment of immune diseases and cancer. The company was founded by Yutaka Tagaya and Nazli Azimi in 2009 and is headquartered in Irvine, CA. | Direttore/Membro del Consiglio | 01/02/2022 |
| ADVERUM BIOTECHNOLOGIES, INC. | Direttore/Membro del Consiglio | 12/05/2021 |
| ALDER BIOPHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 17/01/2019 |
| ALLERGAN, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2015 |
KP Pharmaceuticals LLC
 KP Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology KP Pharmaceuticals LLC is a pharmaceuticals company which develops, manufactures, markets and sells branded prescription pharmaceutical products. The company was founded by John M. Gregory, Randal J. Kirk, Joseph R. Gregory, Jefferson J. Gregory and James E. Gregory in 1993 and is is headquartered in Bristol, TN. | Direttore Tecnico/Scientifico/R&S | 01/01/2011 |
Formazione di Eric Carter
| University of London | Undergraduate Degree |
| University of Cambridge | Doctorate Degree |
| The University of Miami Leonard M. Miller School of Medicine | Doctorate Degree |
| University of Miami | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| GSK PLC | Health Technology |
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| AEON BIOPHARMA, INC. | Health Technology |
| Aziende private | 7 |
|---|---|
KP Pharmaceuticals LLC
KP Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology KP Pharmaceuticals LLC is a pharmaceuticals company which develops, manufactures, markets and sells branded prescription pharmaceutical products. The company was founded by John M. Gregory, Randal J. Kirk, Joseph R. Gregory, Jefferson J. Gregory and James E. Gregory in 1993 and is is headquartered in Bristol, TN. | Health Technology |
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
Bioniz Therapeutics, Inc.
Bioniz Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Bioniz Therapeutics, Inc. operates as a biopharmaceutical firm. The firm engages in the development of peptide therapeutics that selectively and simultaneously inhibit multiple cytokines for the treatment of immune diseases and cancer. The company was founded by Yutaka Tagaya and Nazli Azimi in 2009 and is headquartered in Irvine, CA. | Commercial Services |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | Health Technology |
IACTA Pharmaceuticals, Inc.
 IACTA Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology IACTA Pharmaceuticals, Inc. develops and commercializes eyecare products. Its products include IC 265, for dry eye, and IC 270, for allergic conjunctivitis. The company was founded by Damon Burrows, William Pedranti, and George K. Ng in 2016 and is headquartered in Irvine, CA. | Health Technology |
Visgenx, Inc.
Visgenx, Inc. BiotechnologyHealth Technology Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Eric Carter
